Trial · NCT05439876

Adverse events12

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 12 of 12

Type	Event	Organ system	Group	Affected	At risk
other	mild hand weakness	Nervous system disorders	Melatonin	1	137
other	mild hand weakness	Nervous system disorders	Placebo	0	138
other	decreased appetite	Metabolism and nutrition disorders	Melatonin	1	137
other	decreased appetite	Metabolism and nutrition disorders	Placebo	0	138
other	somnolence and fatigue	Nervous system disorders	Melatonin	2	137
other	somnolence and fatigue	Nervous system disorders	Placebo	0	138
other	increased seizure frequency	Nervous system disorders	Melatonin	0	137
other	increased seizure frequency	Nervous system disorders	Placebo	1	138
other	body tremors	Nervous system disorders	Melatonin	0	137
other	body tremors	Nervous system disorders	Placebo	1	138
other	agitation	Nervous system disorders	Melatonin	0	137
other	agitation	Nervous system disorders	Placebo	1	138

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05439876/events